Due to its potentially addictive qualities, cannabis, commonly known as marijuana, has been subjected to strict regulations in numerous countries, extending to its derived products. One such product is Cannabidiol, often referred to as CBD.
CBD, the second most abundant active compound in cannabis (marijuana), serves as a crucial component of medical marijuana. It is either extracted from the hemp plant, a close relative of marijuana or synthesized in a laboratory.
Unlike typical drugs, CBD is commonly used as a supplement, and despite being derived from the cannabis plant, it surprisingly lacks psychoactive effects, meaning it does not induce a “high” on its own.
According to a report by the World Health Organization, as cited by Harvard University, “CBD does not exhibit any signs of potential abuse or dependence in humans. Thus, there is no documented evidence of public health concerns associated with the use of pure CBD to date.”
In contrast to CBD, THC, another compound found in cannabis, operates differently. Tetrahydrocannabinol (THC) is the primary psychoactive component in marijuana, hashish, and other cannabis-derived preparations, particularly those from Cannabis sativa or synthesized sources.
THC interacts with receptors in the human brain and nervous system, leading to sensations of lightheadedness, commonly known as being “high.”
Let’s take a look at some key statistics about the European CBD Market
- The European CBD market holds the world’s second-largest market share and is projected to reach a value of USD 11.56 billion by 2027.
- It is anticipated that the CBD industry will undergo remarkable compound annual growth between 2023 and 2028, at a rate of 24.57%.
- A recent UK survey revealed that in 2022, nearly 6 million individuals turned to CBD-related products, largely as a result of the anxiety and stress induced by the 2020 lockdown.
- Europe currently has a 31% share of the global CBD market, and its growth is just beginning.
CBD Laws in Europe
Across Europe, the status of CBD varies, with some countries allowing over-the-counter purchases, others permitting medical use only, while some have banned it altogether or have unclear regulations. If you live in Europe or plan to move there, it’s crucial to understand the CBD laws in your chosen country.
| Legal (Over-the-counter use) | Medical Use only | Completely Banned (illegal) | Unclear Regulations | |
| 1. | United Kingdom | Portugal | Georgia | Austria |
| 2. | Bulgaria | Norway | Lithuania | Italy |
| 3. | Netherlands | Malta | Moldova | Belgium |
| 4. | Denmark | North Macedonia | Monaco | Latvia |
| 5. | Poland | Montenegro | Croatia | |
| 6. | Romania | Russia | Estonia | |
| 7. | Germany | Slovakia | Finland | |
| 8. | Switzerland | Spain | ||
| 9. | Spain | Hungary | ||
| 10. | Ukraine | Ireland |
The Rapid Growth of the European CBD Market
The European CBD market holds the world’s second-largest market share and is projected to reach a value of USD 11.56 billion by 2027. Between 2023 and 2028, the CBD industry is expected to witness remarkable growth, with an estimated CAGR of 24.57%. This surge can be attributed to several factors, as revealed by an analysis conducted by MarkNtel Advisors.
One key driver is the increasing legalization of CBD products across various European countries. The EU’s decision in 2020 to classify CBD as non-narcotic has played a pivotal role in this trend. This legal clarification has significantly boosted the sales of CBD products, encompassing cosmetics, recreational usage, and medicinal applications, among others.
CBD Commonly used by patients experiencing pain
Switzerland stands out as a leading nation in the European CBD market, as a result of its progressive approach to the industry. Additionally, the expanding recognition of the health benefits associated with CBD has contributed to its growing market size. CBD products in the form of oils, dietary supplements, and stress management items have gained popularity among consumers.
In the realm of sports, CBD has emerged as a safer alternative to opioids, and athletes are no longer penalized for the presence of CBD in their doping tests. The World Anti-Doping Agency (WADA) removed CBD from its list of prohibited substances for athletes in 2018, primarily due to CBD’s pain relief, anti-inflammatory, and sleep-improving properties, making it a preferred choice among athletes.
Countries like France are conducting extensive research on CBD, and online sales of CBD products, both by private and public entities, continue to expand, further propelling the CBD industry’s growth.
CBD Capsules
Regulatory Framework for Medical Cannabis in Nigeria
In Nigeria, while the Indian Hemp Act of 1966 prohibits the planting, cultivation, and importation of Indian hemp with severe penalties, Section 12 of the Dangerous Drugs Act of 1935 allows the importation of Medicinal Cannabis under specific conditions set by the Minister of Health.
The National Agency for Food and Drug Administration (NAFDAC) is the primary regulatory authority for food and drug products, including medical cannabis. NAFDAC has control over various aspects of medical cannabis, and companies need their approval to sell CBD products in Nigeria.
The National Drug Law Enforcement Agency (NDLEA) and the Federal Ministry of Health also play roles in regulating cannabinoid drugs. Several Acts and Regulations, like the Indian Hemp Act of 1966 and the Dangerous Drugs Act of 1935, govern the use, distribution, and sale of these substances.
In summary, medical cannabis is legal in Nigeria for medicinal purposes, subject to strict regulations. Importation of cannabinoid drugs requires a license from the Minister of Health, and CBD products must be registered with NAFDAC before they can be manufactured, imported, advertised, sold, or distributed in the country.
Nigeria lags significantly in CBD market development compared to Europe and North America, primarily due to its stringent cannabis-related legislation.
